House lawmakers have reintroduced a bill that would require FDA, in consultation with the National Institute on Drug Abuse (NIDA), to issue guidelines on the production of marijuana as part of the legislation’s larger goal to amend the Controlled Substances Act to make marijuana accessible to researchers for medical purposes. The lawmakers, including Reps. Andy Harris (R-MD), Earl Blumenauer (D-OR), Zoe Lofgren (D-CA) and Morgan Griffith (R-VA), previously introduced the bill in 2016 and 2017. This time, Reps. Debbie Dingell...